Dark

ADVM
Adverum Biotechnologies, Inc. Common Stock
stock NASDAQ

At Close

Jul 9, 2025 3:59:30 PM EDT

2.54USD+5.833%(+0.14)98,207

0.00Bid 0.00Ask 0.00Spread

Pre-market

Jul 9, 2025 9:07:30 AM EDT

2.47USD+2.917%(+0.07)100

After-hours

Jul 8, 2025 4:06:30 PM EDT

2.36USD-2.075%(-0.05)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

53.06M

CEO

Leone Patterson

Headquarters

Redwood City, California, USA

Industry

Biotechnology

Next Earnings

Aug 11, 2025 (32d)

Last Split

Mar 21, 20241for10reverse

A XLRN XLV

ADVM Stats

Avg. Vol. 10 Day

455,835

Avg. Vol. 30 Day

281,124

Employees

Market Cap

53,062,462

Shares Out.

20,890,733

On/Off Exchange

58%/42%

6 Month Beta

1.17

1 Year Beta

1.30

2 Year Beta

1.14

3 Year Beta

0.90

52 Week Low

1.78

52 Week High

10.14

SMA50

2.55

SMA200

4.75

1 Week

+12.39%

1 Month

-14.48%

3 Month

-29.05%

6 Month

-40.52%

1 Year

-66.00%

2 Year

-86.49%

5 Year

-98.80%

Profile

adverum (nasdaq: advm) is a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases. we are advancing the development of a robust pipeline of gene therapies that includes product candidates designed to treat rare diseases alpha-1 antitrypsin (a1at) deficiency and hereditary angioedema (hae) as well as wet age-related macular degeneration (wamd). leveraging our next-generation adeno-associated virus (aav)-based directed evolution platform, we generate gene therapies designed to provide durable efficacy by inducing sustained expression of a therapeutic protein.

ADVM Stock Summary

Adverum Biotechnologies, Inc. Common Stock (NASDAQ:ADVM) stock price today is $2.54, and today's volume is 98,207. ADVM is up 5.833% today. The 30 day average volume is 281,124. ADVM market cap is 53.06M with 20,890,733 shares outstanding.